🇺🇸 FDA

Company profile · Sponsor

Praxis

Praxis Precision Medicines

PRAX · NYSE pharma BOSTON, MA, USA
Pipeline
6
Drugs
1
Patents
8

Quick answer

Praxis (PRAX) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 1 drug, and 8 patents to this profile..

Company facts

Ticker PRAX
Exchange NYSE
Company type pharma
Headquarters BOSTON, MA, USA
SEC CIK 0001689548

Pipeline (6)

Search pipeline →

  1. Nimotuzumab

    Praxis

    Pancreatic Cancer, Advanced or Metastatic

    phase 3 small molecule completed

    1 trial

  2. Transcutaneous Cervical Spinal Cord Stimulation

    Praxis

    Spinal Cord Injury Cervical

    phase 3 other active

    1 trial

  3. HIV-1 C4-V3 Polyvalent Peptide Vaccine

    Praxis

    HIV Infections

    phase 1 mab completed

    1 trial

  4. PRX-P4-003, (-)-FCF

    Praxis

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  5. Pneumococcal Vaccine, Polyvalent (23-valent)

    Praxis

    HIV Infections

    phase 1 mab completed

    1 trial

  6. telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP)

    Praxis

    Telemedicine

    other active

    1 trial

Drugs (1)

Search drugs →

  1. sodium iodide i-131

    SODIUM IODIDE I 131

    ORAL approved

Patents (8)

Search patents →

  1. US 12404297

    Salts and crystal forms of GABA-A positive allosteric modulator

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12325711

    3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12259378

    Dynamic clamps and methods of use thereof

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12145939

    Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12077502

    Formulations of T-type calcium channel modulators and methods of use thereof

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11918571

    Compounds and their methods of use

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11919836

    Prodrugs of fencamfamine

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11866439

    Ion channel modulators

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Praxis?

Praxis (PRAX) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 1 drug, and 8 patents to this profile..

What pipeline programs does Praxis sponsor?

We track 6 ClinicalTrials.gov-linked programs for Praxis, including Nimotuzumab and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Praxis company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.